3 Dividend-Paying ADRs to Consider for Portfolio Diversification

Aperam, ASX Limited, and Grupo Cibest each offer ADR dividend yields above 3% and carry a Zacks Rank #1 (Strong Buy). Aperam’s Q2 adjusted EBITDA rose 44% sequentially to about $146 million; ASX FY26 revenue increased 13.3% to roughly $871 million; and Grupo Cibest first-half 2026 profit grew 18.6% year over year to about $1.3 billion, with a 6% yield and a 16% increase in its regular 2026 dividend. ASX faces higher technology-modernization expenses, while the article presents the three stocks as options for international diversification and income.

Analysis

The three yields are not equivalent sources of income. Grupo Cibest’s extraordinary distribution is tied to an asset sale, so annualizing it would overstate recurring shareholder returns; after a strong year-to-date advance, the risk is that investors price a one-off capital return as durable yield. Its thesis is more sensitive to Colombian FX, sovereign/political risk and loan quality than the headline earnings growth implies. Verify recurring earnings, capital ratios and credit costs before adding exposure.

Aperam’s sequential EBITDA and cash-flow rebound may reflect recovery from a weak base rather than a durable demand turn. Stainless-steel pricing, energy costs and import competition can reverse the improvement quickly; debt reduction is supportive only if free cash flow persists. This is cyclical exposure, not a bond substitute.

ASX’s infrastructure economics offer a different earnings driver, but modernization spending creates execution risk: technology delays or cost overruns could absorb operating growth and pressure payout flexibility. Near term, the promotional Strong Buy framing is not a catalyst by itself; the key 1–3 month evidence is follow-through in estimates, cash conversion and guidance. Over 6–18 months, currency and local macro conditions will dominate the diversification benefit. No valuation, dividend-cover or ADR-liquidity data are supplied, so the article does not support a broad yield-basket purchase.

Key Decisions for Investors

• Do not chase CIB on the stated yield after its sharp run. Treat the sale-related distribution as non-recurring; revisit only after checking recurring earnings, capital adequacy, credit costs and the regular-dividend outlook. Falsifier: deterioration in asset quality or a cut to the regular payout.
• Keep APAM on a cyclical watchlist rather than treating it as defensive income. Consider a small, staged position only if the next report confirms positive free cash flow and further debt reduction; exit the thesis if cash generation reverses or management points to weakening steel demand/pricing.
• For diversified income exposure, assess ASX separately from the banks and metals names; wait for evidence that technology-modernization costs are contained and earnings growth converts to cash. No trade recommendation without current valuation, payout coverage and ADR trading/liquidity checks.